EUVIMEDEUVIMED felfedezése
Open access · CC BY 4.0

Long‐term prognosis of vaccine‐induced contact allergy to aluminium: Third patch‐test with additional test preparations

Anette Gente Lidholm, Annica Inerot iD, Martin Gillstedt, Elisabet Bergfors, Birger Trollfors

Contact Dermatitis · 2023

DOI: 10.1111/cod.14386 ↗

At a glance

Journal article in Contact Dermatitis, 2023. Written by Anette Gente Lidholm and 4 co-authors. Institution: Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Major MEDLINE topics: Dermatitis, Allergic Contact, Pertussis Vaccine. Cited 2 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY 4.0). Funded by: ALF-Agreement.

AbsztraktSubjectsBibliográfiai adatokCiteRelated studies

Abstract (original language)

Background

A high incidence of local itching subcutaneous nodules and aluminium allergy was observed in clinical trials of a new aluminium adsorbed pertussis vaccine in Gothenburg, Sweden, in the 1990s. A total of 495 children with itching nodules were patch tested with aluminium chloride hexahydrate 2% and an empty Finn Chamber®, 377 (76%) with positive reactions. When 241 of them were re‐tested some years later 186 (3 out of 4) had unexpectedly lost their patch test reactivity.

Aim

To investigate the long‐term prognosis of vaccine‐induced contact allergy to aluminium by a third patch test about 20 years after Patch test I.

Methods

Twenty individuals with positive and 11 with negative results in Patch test II were tested a third time with the same sensitisers as in in the first two tests. Three additional aluminium preparations were also tested.

Results

A total 15 out of 20 persons with positive results in the second test had lost their patch test reactivity. Two of 11 with negative tests had turned positive again. The addition of the preparations gave no conclusive results.

Conclusion

Contact allergy to aluminium caused by vaccination with aluminium‐adsorbed vaccines in childhood seems to fade away with time as measured by loss of patch test reactivity.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactPertussis VaccineChildHumansAluminumPatch TestsPrognosisPruritusTest Taking Skills

Author keywords

aluminiumaluminium adsorbed vaccinesaluminium allergychildhood vaccinationcontact allergyimmunologypatch testside effectstolerance

Substances

AluminumPertussis Vaccine

Authors and institutions

  • Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Paediatrics, Sahlgrenska University Hospital, Gothenburg, Sweden.

ORCID profiles: Annica Inerot

Funding

  • ALF-Agreement

Cite

APA

Lidholm, A. G., Inerot, A., Gillstedt, M., Bergfors, E., & Trollfors, B. (2023). Long‐term prognosis of vaccine‐induced contact allergy to aluminium: Third patch‐test with additional test preparations. Contact Dermatitis. https://doi.org/10.1111/cod.14386

Vancouver

Lidholm AG, Inerot A, Gillstedt M, Bergfors E, Trollfors B. Long‐term prognosis of vaccine‐induced contact allergy to aluminium: Third patch‐test with additional test preparations. Contact Dermatitis. 2023. doi:10.1111/cod.14386

BibTeX
@article{Lidholm2023,
  author = {Lidholm, Anette Gente and Inerot, Annica and Gillstedt, Martin and Bergfors, Elisabet and Trollfors, Birger},
  title = {Long‐term prognosis of vaccine‐induced contact allergy to aluminium: Third patch‐test with additional test preparations},
  journal = {Contact Dermatitis},
  year = {2023},
  doi = {10.1111/cod.14386}
}
Start for free →